|
1
|
Delbary-Gossart S, Lee S, Baroni M,
Lamarche I, Arnone M, Canolle B, Lin A, Sacramento J, Salegio EA,
Castel MN, et al: A novel inhibitor of p75-neurotrophin receptor
improves functional outcomes in two models of traumatic brain
injury. Brain. 139:1762–1782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scott G, Zetterberg H, Jolly A, Cole JH,
De Simoni S, Jenkins PO, Feeney C, Owen DR, Lingford-Hughes A,
Howes O, et al: Minocycline reduces chronic microglial activation
after brain trauma but increases neurodegeneration. Brain.
141:459–471. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang ZG, Cheng Y, Yu XC, Ye LB, Xia QH,
Johnson NR, Wei X, Chen DQ, Cao G, Fu XB, et al: bFGF protects
against blood-brain barrier damage through junction protein
regulation via PI3K-Akt-rac1 pathway following traumatic brain
injury. Mol Neurobiol. 53:7298–7311. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu J, Frerich JM, Turtzo LC, Li S, Chiang
J, Yang C, Wang X, Zhang C, Wu C, Sun Z, et al: Histone deacetylase
inhibitors are neuroprotective and preserve NGF-mediated cell
survival following traumatic brain injury. Proc Natl Acad Sci USA.
110:10747–10752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Z, Wang H, Shi X, Li L, Zhou M, Ding
H, Yang Y, Li X and Ding K: DL-3-n-Butylphthalide (NBP) Provides
Neuroprotection in the mice models after traumatic brain injury via
Nrf2-ARE signaling pathway. Neurochem Res. 42:1375–1386. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bramlett HM and Dietrich WD: Long-term
consequences of traumatic brain injury: Current status of potential
mechanisms of injury and neurological outcomes. J Neurotrauma.
32:1834–1848. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gyoneva S and Ransohoff RM: Inflammatory
reaction after traumatic brain injury: Therapeutic potential of
targeting cell-cell communication by chemokines. Trends Pharmacol
Sci. 36:471–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Liu Z, Ren H, Zhang L, Gao S, Ren
L, Chai Z, Meza-Romero R, Benedek G, Vandenbark AA, et al:
DRα1-MOG-35-55 treatment reduces lesion volumes and improves
neurological deficits after traumatic brain injury. Metab Brain
Dis. 32:1395–1402. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Ma QQ, Yan Y, Xu FD, Zhang XY, Zhou
WQ and Feng ZC: Edaravone attenuates hippocampal damage in an
infant mouse model of pneumococcal meningitis by reducing HMGB1 and
iNOS expression via the Nrf2/HO-1 pathway. Acta Pharmacol Sin.
37:1298–1306. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumar A, Stoica BA, Loane DJ, Yang M,
Abulwerdi G, Khan N, Kumar A, Thom SR and Faden AI:
Microglial-derived microparticles mediate neuroinflammation after
traumatic brain injury. J Neuroinflammation. 14:472017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Wang H, Zhou M, Li X, Fang Z, Gao
H, Li Y and Hu W: Valproic acid attenuates traumatic brain
injury-induced inflammation in vivo: Involvement of autophagy and
the Nrf2/ARE signaling pathway. Front Mol Neurosci. 11:1172018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mayeux JP, Teng SX, Katz PS, Gilpin NW and
Molina PE: Traumatic brain injury induces neuroinflammation and
neuronal degeneration that is associated with escalated alcohol
self- administration in rats. Behav Brain Res. 279:22–30. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishii T, Kwon H, Hiscott J, Mosialos G and
Koromilas AE: Activation of the I kappa B alpha kinase (IKK)
complex by double-stranded RNA-binding defective and catalytic
inactive mutants of the interferon-inducible protein kinase PKR.
Oncogene. 20:1900–1912. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta SC, Sundaram C, Reuter S and
Aggarwal BB: Inhibiting NF-κB activation by small molecules as a
therapeutic strategy. Biochim Biophys Acta. 1799:775–787. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vomund S, Schäfer A, Parnham MJ, Brüne B
and von Knethen A: Nrf2, the master regulator of anti-oxidative
responses. Int J Mol Sci. 18:E27722017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fabrizio FP, Sparaneo A, Trombetta D and
Muscarella LA: Epigenetic versus genetic deregulation of the
KEAP1/NRF2 axis in solid tumors: Focus on methylation and noncoding
RNAs. Oxid Med Cell Longev. 2018:24920632018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian A, Ma H, Zhang R, Cui Y and Wan C:
Edaravone improves spatial memory and modulates endoplasmic
reticulum stress- mediated apoptosis after abdominal surgery in
mice. Exp Ther Med. 14:355–360. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pan H, Wang H, Zhu L, Mao L, Qiao L and Su
X: Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin
in cultured mice astrocytes. Neurochem Res. 36:2434–2441. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiazza F, Chegaev K, Rogazzo M, Cutrin
JC, Benetti E, Lazzarato L, Fruttero R and Collino M: A nitric
oxide-donor furoxan moiety improves the efficacy of edaravone
against early renal dysfunction and injury evoked by
ischemia/reperfusion. Oxid Med Cell Longev. 2015:8046592015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jami MS, Salehi-Najafabadi Z, Ahmadinejad
F, Hoedt E, Chaleshtori MH, Ghatrehsamani M, Neubert TA, Larsen JP
and Møller SG: Edaravone leads to proteome changes indicative of
neuronal cell protection in response to oxidative stress. Neurochem
Int. 90:134–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lei S, Zhang P, Li W, Gao M, He X, Zheng
J, Li X, Wang X, Wang N, Zhang J, et al: Pre- and posttreatment
with edaravone protects CA1 hippocampus and enhances neurogenesis
in the subgranular zone of dentate gyrus after transient global
cerebral ischemia in rats. ASN Neuro. 6:17590914145584172014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou S, Yu G, Chi L, Zhu J, Zhang W, Zhang
Y and Zhang L: Neuroprotective effects of edaravone on cognitive
deficit, oxidative stress and tau hyperphosphorylation induced by
intracerebroventricular streptozotocin in rats. Neurotoxicology.
38:136–145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujiwara N, Som AT, Pham LD, Lee BJ,
Mandeville ET, Lo EH and Arai K: A free radical scavenger edaravone
suppresses systemic inflammatory responses in a rat transient focal
ischemia model. Neurosci Lett. 633:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Choi YK, Maki T, Mandeville ET, Koh SH,
Hayakawa K, Arai K, Kim YM, Whalen MJ, Xing C, Wang X, et al: Dual
effects of carbon monoxide on pericytes and neurogenesis in
traumatic brain injury. Nat Med. 22:1335–1341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bedi SS, Aertker BM, Liao GP, Caplan HW,
Bhattarai D, Mandy F, Mandy F, Fernandez LG, Zelnick P, Mitchell
MB, et al: Therapeutic time window of multipotent adult progenitor
therapy after traumatic brain injury. J Neuroinflammation.
15:842018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lozano D, Gonzales-Portillo GS, Acosta S,
de la Pena I, Tajiri N, Kaneko Y and Borlongan CV:
Neuroinflammatory responses to traumatic brain injury: Etiology,
clinical consequences, and therapeutic opportunities.
Neuropsychiatr Dis Treat. 11:97–106. 2015.PubMed/NCBI
|
|
28
|
Liu Y, Bao Z, Xu X, Chao H, Lin C, Li Z,
Liu Y, Wang X, You Y, Liu N and Ji J: Extracellular
Signal-Regulated Kinase/Nuclear Factor-Erythroid2-like2/Heme
Oxygenase-1 Pathway-Mediated Mitophagy Alleviates Traumatic Brain
Injury-Induced Intestinal Mucosa Damage and Epithelial Barrier
Dysfunction. J Neurotrauma. 34:2119–2131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang WW, Bai F, Wang J, Zheng RH, Yang
LW, James EA and Zhao ZQ: Edaravone inhibits pressure
overload-induced cardiac fibrosis and dysfunction by reducing
expression of angiotensin II AT1 receptor. Drug Des Devel Ther.
11:3019–3033. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Higashi Y, Hoshijima M, Yawata T, Nobumoto
A, Tsuda M, Shimizu T, Saito M and Ueba T: Suppression of oxidative
stress and 5-lipoxygenase activation by edaravone improves
depressive-like behavior after concussion. J Neurotrauma.
31:1689–1699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang GH, Jiang ZL, Li YC, Li X, Shi H, Gao
YQ, Vosler PS and Chen J: Free-radical scavenger edaravone
treatment confers neuroprotection against traumatic brain injury in
rats. J Neurotrauma. 28:2123–2134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rowe RK, Harrison JL, Zhang H, Bachstetter
AD, Hesson DP, O'Hara BF, Greene MI and Lifshitz J: Novel TNF
receptor-1 inhibitors identified as potential therapeutic
candidates for traumatic brain injury. J Neuroinflammation.
15:1542018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gao YY, Zhang ZH, Zhuang Z, Lu Y, Wu LY,
Ye ZN, Zhang XS, Chen CL, Li W and Hang CH: Recombinant milk fat
globule-EGF factor-8 reduces apoptosis via integrin β3/FAK/PI3K/AKT
signaling pathway in rats after traumatic brain injury. Cell Death
Dis. 9:8452018. View Article : Google Scholar : PubMed/NCBI
|
